Wonder who’s making the money on this?
Wonder who’s making the money on this?
Archive: https://archive.today/uY3MY
From the post:
>Investors and AIDS activists had been eagerly awaiting the regulatory decision for a drug some have said could help end the 44-year-old HIV epidemic. Lenacapavir, part of a class of drugs known as capsid inhibitors, proved nearly 100% effective at preventing HIV in large trials last year, raising new hope of interrupting transmission of the virus that infects 1.3 million people a year. The academic journal Science dubbed the experimental pre-exposure prophylaxis (PrEP) drug the 2024 Breakthrough of the Year.
Archive: https://archive.today/uY3MY
From the post:
>>Investors and AIDS activists had been eagerly awaiting the regulatory decision for a drug some have said could help end the 44-year-old HIV epidemic.
Lenacapavir, part of a class of drugs known as capsid inhibitors, proved nearly 100% effective at preventing HIV in large trials last year, raising new hope of interrupting transmission of the virus that infects 1.3 million people a year.
The academic journal Science dubbed the experimental pre-exposure prophylaxis (PrEP) drug the 2024 Breakthrough of the Year.
(post is archived)